Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction

Abstract Aims Heart failure with mid‐range ejection fraction (HFmrEF) has been proposed as a distinct HF phenotype, but whether patients on this category fare worse, similarly, or better than those with HF with reduced EF (HFrEF) or preserved EF (HFpEF) in terms of rehospitalization risks over time...

Full description

Bibliographic Details
Published in:	ESC Heart Failure
Main Authors:	Enrique Santas, Rafael de laEspriella, Patricia Palau, Gema Miñana, Martina Amiguet, Juan Sanchis, Josep Lupón, Antoni Bayes‐Genís, Francisco Javier Chorro, Julio Núñez Villota
Format:	Article
Language:	English
Published:	Wiley 2020-06-01
Subjects:	Heart failure Readmissions Heart failure with mid‐range ejection fraction Recurrent events
Online Access:	https://doi.org/10.1002/ehf2.12683

Similar Items

Rehospitalization, mortality and associated variables in primary care patients with heart failure and preserved ejection fraction after first hospitalization
by: Victoria Cendrós, et al.
Published: (2025-06-01)

Heart Failure Drug Class Effects on 30-Day Readmission Rates in Patients with Heart Failure with Preserved Ejection Fraction: A Retrospective Single Center Study
by: Priyanka Parajuli, et al.
Published: (2020-05-01)

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
by: Kaiyuan Zhu, et al.
Published: (2021-07-01)

Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction
by: Mohammed Al‐Jarallah, et al.
Published: (2020-02-01)

Prediction model of rehospitalization and mortality in heart failure patients with preserved and mildly reduced ejection fraction: the AD2NNER risk score
by: Flavia-Mihaela Stoiculescu, et al.
Published: (2025-07-01)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
by: Chiara Borrelli, et al.
Published: (2019-09-01)

Effect of therapy on the dynamics of collagen metabolism markers in older patients with heart failure with mid-range ejection fraction and coronary artery disease
by: O. A. Osipova, et al.
Published: (2020-11-01)

The modulating effect of circulating carbohydrate antigen 125 on ST2 and long-term recurrent morbidity burden
by: Elena Revuelta-López, et al.
Published: (2025-01-01)

Clinical characteristics and outcomes in Asian patients with heart failure with mildly reduced ejection fraction
by: Julian Cheong Kiat Tay, et al.
Published: (2024-07-01)

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON‐HF trial
by: Lars H. Lund, et al.
Published: (2022-02-01)

Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING‐HF trial
by: Patricia Palau, et al.
Published: (2024-04-01)

Association between mitral annulus calcification and subtypes of heart failure rehospitalization
by: Yuta Kato, et al.
Published: (2023-04-01)

Heart failure with mid‐range ejection fraction: characterization of patients from the PINNACLE Registry®
by: Nasrien E. Ibrahim, et al.
Published: (2019-08-01)

The clinical characteristics of acute heart failure patients with mid-range ejection fraction in Turkey: A subgroup analysis from journey HF-TR study
by: Umit Yasar Sinan, et al.
Published: (2020-01-01)

Prognostic Value of Inflammatory Cytokines in Predicting Hospital Readmissions in Heart Failure with Preserved Ejection Fraction
by: Zhao Z, et al.
Published: (2024-05-01)

Prognostic value of growth differentiation factor‐15 in heart failure among whole ejection fraction phenotypes
by: Lyu Lyu, et al.
Published: (2024-08-01)

Trends in MitraClip Placements and Predictors of 90-Day Heart Failure Rehospitalization: A Nationwide Analysis
by: Vivek Joseph Varughese, et al.
Published: (2025-06-01)

Left Ventricular Ejection Fraction in Heart Failure: Crazy, Stupid Love—and Maybe, Redemption
by: Milton Packer
Published: (2024-04-01)

Prediction of 90 day readmission in heart failure with preserved ejection fraction by interpretable machine learning
by: Baojia Zheng, et al.
Published: (2024-12-01)

Characterizing Heart Failure Across the Spectrum of the Preserved Ejection Fraction: Does Heart Failure With Supranormal Ejection Fraction Exist? Data From the Swedish Heart Failure Registry
by: Laura Landucci, et al.
Published: (2025-03-01)

Effect of sacubitril valsartan on heart failure with mid-range or preserved ejection fraction in patients on maintenance hemodialysis: real-world experience in a single-center, prospective study
by: Xiao-mei Huang, et al.
Published: (2024-01-01)

Clinical management of heart failure with improved ejection fraction: treatment and maintenance
by: XU Tianyun, et al.
Published: (2025-04-01)

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
by: Valeria Conti, et al.
Published: (2020-11-01)

Diabetic microvascular complications predicts non‐heart failure with reduced ejection fraction in type 2 diabetes
by: Mayu Tochiya, et al.
Published: (2023-04-01)

Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes
by: D. A. Lebedev, et al.
Published: (2020-11-01)

Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review
by: Igor V. Zhirov, et al.
Published: (2023-11-01)

The inverted U-shaped association between blood fibrinogen and rehospitalization risk in patients with heart failure
by: Zhenyan Xu, et al.
Published: (2024-07-01)

Association of ambient temperature and acute heart failure with preserved and reduced ejection fraction
by: Takahiro Jimba, et al.
Published: (2022-10-01)

Association of Depression and Anxiety with Cardiac Structural and Functional Characteristics in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
by: Timea Magdolna Szabo, et al.
Published: (2023-03-01)

Тhe uncharted middle ground – when the patient asks, but the guideliness don’t answer
by: Iskra Bayraktarova, et al.
Published: (2021-07-01)

Heart Failure with Preserved Ejection Fraction in Egypt: An Expert Opinion
by: Magdy Abdelhamid, et al.
Published: (2025-03-01)

Vericiguat: The Fifth Harmony of Heart Failure with Reduced Ejection Fraction
by: Luigi Falco, et al.
Published: (2023-09-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Heart failure with preserved left ventricular ejection fraction – clinical perspectives
by: Małgorzata Niemiec, et al.
Published: (2025-07-01)

Impact of sleep apnoea on 30 day hospital readmission rate and cost in heart failure with reduced ejection fraction
by: Don Mathew, et al.
Published: (2023-08-01)

Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction
by: Xin He, et al.
Published: (2021-08-01)

The effects on rehospitalization rate of transitional care using information communication technology in patients with heart failure: A scoping review
by: KaiXin Qi, et al.
Published: (2023-12-01)

New possibilities in pharmacotherapy for the heart failure with reduced ejection fraction treatment in patients with recent deterioration
by: I. V. Gribkova
Published: (2024-03-01)

IL‐6 and hsCRP predict cardiovascular mortality in patients with heart failure with preserved ejection fraction
by: Martin Berger, et al.
Published: (2024-12-01)

Development and Challenges of Pre-Heart Failure with Preserved Ejection Fraction
by: Guoju Dong
Published: (2023-09-01)